⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

January 1, 2004Recent Progress in Hormone ResearchOpen Access

Balancing Contractility and Energy Production: The Role of Myocyte Enhancer Factor 2 (MEF2) in Cardiac Hypertrophy

View Full Paper

Ask AI

Bookmark

Share

Design

Review

Authors

MCMichael P. CzubrytSt. Boniface Hospital

Discussion

Loading...

Member takes

Implication

No immediate clinical implications; leaves open MEF2 as a mechanistic target for hypertrophy research.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Michael P. Czubryt (2004) studied this question.

synapsesocial.com/papers/69b32afc52eef3fac5b3f578 https://doi.org/10.1210/rp.59.1.105

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo2000 · 526 citations
2Increased Adenosine Monophosphate–Activated Protein Kinase Activity in Rat Hearts With Pressure-Overload Hypertrophy2001 · 309 citations
3A mechanistic role for cardiac myocyte apoptosis in heart failure2003 · 745 citations
4Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy <i>in vivo</i>2001 · 295 citations
5Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts1994 · 582 citations